Cytosorbents (CTSO) Tops Q2 EPS by 1c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $9.68 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'
• Stifel on Bally's Corp (BALY): 'expect shares to continue to trade mainly on development project cost & financing updates'